
India rejects ARV patent applications, saving “countless lives”
NAIROBI: (PlusNews) - AIDS activists have praised a decision by the Indian patent office to reject patent applications for two life-prolonging antiretroviral (ARV) drugs, allowing Indian manufacturers to keep on making and exporting generic versions.













